Ads by Google
Prostate cancer screening usually means a blood test for prostate specific antigen (PSA) and might include a digital rectal examination (DRE) of the prostate.
Prostate cancer rates are extremely high in African American men. They develop prostate cancer 60 percent more often than do European Americans
Low grade prostate cancer may be slowed if men make healthful changes to their diet, physical activity level, and stress management techniques.
Prostate cancer often metastasizes to bone forming painful tumors. First step toward finding a way to block the development of metastatic bone tumors in men with prostate cancer.
When men with clinically localized prostate cancer are treated with high dose radiation therapy, they are more likely to be free from an increasing PSA level.
Ablatherm HIFU is a highly precise procedure using high intensity, focused ultrasound to eliminate prostate cancer.
The findings may offer hope to identify patients who are more likely to have a recurring or life threatening prostate cancer.
Although it is easy to diagnose more prostate cancer, it is not easy to know who has clinically important disease.
A new study indicates there is no specific PSA value that has both high sensitivity and high specificity for monitoring healthy men for prostate cancer.
Given recent randomized trials reporting significant improvement in survival with chemotherapy for patients with hormone refractory prostate cancer, a number of important questions persist.
Rate of increase in PSA value Prior to diagnosis of Prostate Cancer predicts risk of death following Radiation Therapy.
Clinical factors can help determine risk of prostate cancer death following 'biochemical' cancer recurrence after radical prostatectomy.
Men with early stage prostate cancer who make intensive changes in diet and lifestyle may stop or perhaps even reverse the progression of their illness, according to a new study.
In Canada, prostate cancer is the most common cancer threat to men.
Study finds that a cancer vaccine combined with hormone deprivation therapy can help patients with recurrence of prostate cancer.
A drug that is currently used to treat an enlarged prostate may improve the accuracy of prostate biopsies, a pilot study shows.
Early screening of prostate cancer in asymptomatic men may reduce their risk of death from metastatic prostate cancer by as much as 35 per cent.
Identifying high risk prostate cancer means more prudent treatment decisions, fewer unnecessary biopsies.
The study determines if this combination should be developed as a treatment for advanced prostate cancer.
A diagnostic scan may help localize recurrent prostate disease in men who have had surgical removal of the prostate and show early signs of recurrence.
PSA remains a vital tool for determining risk of recurrence in prostate cancer patients.
Among African Americans with prostate cancer, a tumor suppressing gene called GSTP1 is inactivated at a rate 3.5 times higher than among Caucasians.
Prostate cancer risk my be decreased by increased exposure to sunlight because the body manufactures the active form of vitamin D from exposure to sunlight.
According to the Prostate Cancer Research Foundation of Canada, at least one in every seven Canadian men is expected to develop the disease in their lifetime.
Prostate cancer patients who reach a very low level PSA (prostate specific antigen) after combined radiation treatment have a 99 percent chance of survival free from disease.
New Nutrition and Prostate Cancer Guide Issued by the Prostate Cancer Foundation for Father's Day.
The study shows the benefits of flaxseed in reducing the growth and development of prostate cancer.
Men with spouses, partners fare better after treatment for prostate cancer than single men, UCLA study finds
Unique Radiation Treatment Designed by Stanford to Fight Prostate Cancer.
Results Point to Novel Pathway for Development of Prostate Cancer. Prostate cancer is among the most prevalent cancers worldwide and is the second leading cause of male cancer related death in the United States.